An important role for glucagon in the regulation of glucose production in vivo. 1976

J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
February 1977, The Journal of clinical investigation,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
April 1980, The Journal of clinical endocrinology and metabolism,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
January 1980, The American journal of physiology,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
January 1979, Diabetes,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
January 1978, Biochemical Society transactions,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
December 1976, The Journal of clinical investigation,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
December 1987, Biochemical Society transactions,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
November 1975, Pediatric research,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
January 1997, Canadian journal of physiology and pharmacology,
J E Liljenquist, and J L Chiassan, and A D Cherrington, and U Keller, and A S Jennings, and J D Bomboy, and W W Lacy
January 1987, Diabetes/metabolism reviews,
Copied contents to your clipboard!